94 Participants Needed

ERAS Anesthesia Techniques for Knee Surgery Recovery

(EKAT-TeleTPS Trial)

GB
Overseen ByGeorge Birch, BS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Hospital for Special Surgery, New York
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests two anesthesia techniques to determine which aids recovery better after knee replacement surgery. The Adductor Canal Block with sham catheter involves a single injection to numb the knee area, while the Continuous Adductor Canal Catheter (ACC) provides continuous numbing. The trial seeks participants with osteoarthritis who are scheduled for knee replacement surgery with specific doctors, live near the hospital, and have a smartphone. The goal is to identify which method reduces pain and improves recovery. As an unphased trial, it offers participants the chance to contribute to valuable research that could enhance recovery techniques for future patients.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but it excludes people who regularly use gabapentin or pregabalin. It's best to discuss your specific medications with the trial team.

What prior data suggests that these anesthesia techniques are safe for knee surgery recovery?

Research shows that the adductor canal block, a type of pain relief, is generally safe for reducing pain after knee surgery. Studies indicate that a continuous adductor canal catheter (ACC) can manage pain while still allowing movement. This method has been successfully used in outpatient settings, often enabling patients to go home the same day after surgery.

The main safety concerns include falls, infections, nerve injury, and muscle weakness. However, reports suggest these issues are rare. Most patients tolerate the ACC well and can move around soon after surgery. The continuous catheter method appears to improve recovery, making it a promising option for managing pain in knee surgeries.12345

Why are researchers excited about this trial?

Researchers are excited about these anesthesia techniques for knee surgery recovery because they aim to enhance pain management and speed up recovery. The Continuous Adductor Canal Catheter (ACC) is unique as it continuously delivers local anesthetic to the adductor canal, potentially improving pain control over traditional single-shot blocks. Meanwhile, the Adductor Canal block with a sham catheter is designed to assess the effectiveness of continuous delivery compared to a standard block, providing valuable insights into optimal pain management strategies. These approaches could revolutionize post-operative care by improving comfort and reducing reliance on systemic pain medications.

What evidence suggests that this trial's anesthetic techniques could be effective for knee surgery recovery?

Research has shown that a continuous adductor canal catheter (ACC), which participants in this trial may receive, can reduce pain after knee surgery. This method provides better pain relief than single injections, which wear off more quickly. Additionally, patients using the ACC often regain knee movement faster after surgery. One study found that the ACC improved knee movement by about 11.77 degrees, a significant improvement. Overall, the continuous method aids in both pain management and quicker physical recovery after knee surgery. Another group in this trial will receive an adductor canal block with a sham catheter for comparison.23678

Who Is on the Research Team?

DK

David Kim, MD

Principal Investigator

Hospital for Special Surgery, New York

Are You a Good Fit for This Trial?

This trial is for English-speaking adults aged 18-65 with osteoarthritis, scheduled for knee replacement surgery using regional anesthesia. They must live within an hour of the hospital, be able to follow the study protocol, have a smartphone, and have home caregivers if needed. Excluded are those with diabetes, chronic pain or high pain catastrophizing scores, severe knee deformities, no home caregivers for catheter care, ASA status III/IV patients, those unable to manage a catheter at home or going to rehab facilities post-surgery.

Inclusion Criteria

Has a smart phone
Patients with osteoarthritis scheduled for a primary total knee arthroplasty with a participating surgeon
You are scheduled to receive regional anesthesia during the study.
See 3 more

Exclusion Criteria

You have a severe bending or twisting problem in your joints.
Patients undergoing general anesthesia
Diabetes
See 10 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo total knee arthroplasty with either a continuous adductor canal catheter or a single-shot adductor canal block

1 day
1 visit (in-person, day of surgery)

Post-operative Monitoring

Participants' opioid consumption is monitored during the post-anesthesia care unit stay and the 24-48 hour period post spinal induction

2 days
In-patient monitoring

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Adductor Canal block with sham catheter
  • Continuous Adductor Canal Catheter (ACC)
Trial Overview The trial compares two anesthesia techniques in knee replacements: one uses a single-shot nerve block plus local injections (PAI & IPACK), while the other adds a continuous nerve block through a catheter (ACC). The goal is to see which method provides better pain control during recovery.
How Is the Trial Designed?
2Treatment groups
Active Control
Placebo Group
Group I: Continuous Adductor Canal Catheter (ACC)Active Control1 Intervention
Group II: Adductor Canal block with sham catheterPlacebo Group1 Intervention

Adductor Canal block with sham catheter is already approved in European Union, United States, Canada for the following indications:

🇪🇺
Approved in European Union as Adductor Canal Block for:
🇺🇸
Approved in United States as Adductor Canal Block for:
🇨🇦
Approved in Canada as Adductor Canal Block for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Hospital for Special Surgery, New York

Lead Sponsor

Trials
257
Recruited
61,800+

Published Research Related to This Trial

In a study of 57 total knee arthroplasty patients, both proximal and distal adductor canal blocks (ACBs) provided similar levels of postoperative pain relief, as indicated by comparable opioid consumption and pain scores.
While the proximal ACB group showed a trend towards better functional mobility (measured by the 'Up and Go' test), this difference was not statistically significant, suggesting that both techniques are equally effective for pain management post-surgery.
A Randomized Comparison of Pain Control and Functional Mobility between Proximal and Distal Adductor Canal Blocks for Total Knee Replacement.Romano, C., Lloyd, A., Nair, S., et al.[2022]
The SAMBBA technique preserves the anterior cruciate ligament (ACL) remnant during reconstruction, which may enhance graft tendon vascularity and improve healing outcomes.
This method also maintains the semitendinosus tibial insertion, utilizing standard surgical portals and equipment, potentially simplifying the procedure while maximizing biological benefits.
Anterior Cruciate Ligament Reconstruction and Preservation: The Single-Anteromedial Bundle Biological Augmentation (SAMBBA) Technique.Sonnery-Cottet, B., Freychet, B., Murphy, CG., et al.[2022]
In a study of 180 patients undergoing total knee arthroplasty, a single injection of adductor canal block (ACB) with or without intravenous dexamethasone was found to be non-inferior to a continuous catheter in terms of opioid consumption at 24 hours post-surgery.
Both the single injection ACB with and without dexamethasone significantly reduced opioid use compared to the catheter method, suggesting that these options could facilitate faster recovery and earlier discharge for patients.
A Randomized Non-Inferiority Trial of Adductor Canal Block for Analgesia After Total Knee Arthroplasty: Single Injection Versus Catheter Technique.Lee, S., Rooban, N., Vaghadia, H., et al.[2022]

Citations

The effects of continuous catheter adductor canal block for ...Our meta-analysis appears to demonstrate that continuous administration of analgesia through an adductor canal catheter provides greater pain reduction in ...
Outpatient continuous adductor canal block (CACB) for ...Single-injection adductor canal blocks (SACB) provide effective but short-lived pain relief after total knee arthroplasty, with limited ...
Continuous Adductor Canal Block in Outpatient Total Knee ...Postoperative continuous adductor canal block for total knee arthroplasty improves pain and functional recovery: A randomized controlled clinical trial. J ...
Effectiveness of continuous adductor canal block versus ...This study aimed to evaluate the effectiveness of continuous adductor canal block (CACB) versus continuous femoral nerve block (CFNB) in postoperative analgesia ...
Postoperative continuous adductor canal block for total ...Paired outcomes at 6 weeks compared to baseline ROM, showed significant improvement in knee ROM with a cACB (mean difference 11.77°, 95% CI: 3.1–20.5°, P = 0.01) ...
6.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/40177059/
Adductor canal block in total knee arthroplasty: a scoping ...Adductor canal block is a safe and potentially effective peripheral nerve block for reducing postoperative pain after total knee arthroplasty while preserving ...
Analgesic Efficacy of Adductor Canal Block in Total Knee ...The outcomes assessed included cumulative analgesic consumption, pain at rest or during movement, ability to ambulate, quadriceps strength, and complications ( ...
Review Article Adductor canal block in total knee arthroplastyImportant safety outcomes were falls, infection, nerve injury, and quadriceps weakness. ... Song, et al. Is continuous catheter adductor canal block better than ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security